Abstract Background/Aims: On behalf of the Drug and Therapeutics, and Ethics Committees
of the Pediatric Endocrine Society, we sought to update the guidelines published in 2003 on …

Growth hormone (GH) research and its clinical application for the treatment of growth
disorders span more than a century. During the first half of the 20th century, clinical …

Abstract The Growth Hormone Research Society (GRS) convened a Workshop in March
2019 to evaluate the diagnosis and therapy of short stature in children. Forty-six …

Context: Recombinant human GH (rhGH) therapy in Prader-Willi syndrome (PWS) has been
used by the medical community and advocated by parental support groups since its …

The important role of GH in the control of mammalian longevity was first deduced from
extended longevity of mice with genetic GH deficiency (GHD) or GH resistance. Mice with …

Growth hormone deficiency (GHD) is a clinical syndrome that can manifest either as isolated
or associated with additional pituitary hormone deficiencies. Although diminished height …

Accurate measurement of height and weight using standardized techniques is a
fundamental component of pediatric medical visits. Calculation of height velocity over time …

Growth hormone deficiency (GHD) is a rare but important cause of short stature in childhood
with a prevalence of 1 in 4000. The diagnosis is currently based on an assessment of …

The syndrome of impaired GH secretion (GH deficiency) in childhood and adolescence had
been identified at the end of the 19th century. Its non-acquired variant (naGHD) is, at …

Short stature remains the most common reason for referral to a pediatric Endocrinologist and
its management remains a challenge. One of the main controversies is the diagnosis of …